4//SEC Filing
SCOTT GREGORY J 4
Accession 0001179110-18-011734
CIK 0001211351other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 6:33 PM ET
Size
10.5 KB
Accession
0001179110-18-011734
Insider Transaction Report
Form 4
SCOTT GREGORY J
President
Transactions
- Award
Common Stock
2018-09-28+97,150→ 369,572 total - Award
Stock Appreciation Rights
2018-08-27+153,688→ 153,688 totalExercise: $4.88Exp: 2028-08-27→ Common Stock (153,688 underlying) - Award
Common Stock
2018-08-27+153,688→ 272,422 total
Holdings
- 176,340(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The reporting person was awarded restricted stock which vests on August 27, 2021.
- [F2]The reporting person was granted an award of performance-based restricted stock that vests subject to the Company achieving fiscal year target EBITDA levels for fiscal years 2019, 2020 and 2021, and continued employment with the Company through March 2022. For each fiscal year EBITDA target achieved by the Company, the reporting person will earn 24,287 shares of restricted stock. If the Company achieves the fiscal year target EBITDA goal for the combined fiscal years 2019, 2020 and 2021, the reporting person will earn 24,289 shares of restricted stock. Any earned shares will vest in March 2022. If the Company does not achieve any of the fiscal year EBITDA goals, the performance shares related to that performance period will be forfeited.
- [F3]Includes 10,000 shares of common stock; 54,367 vested deferred stock units; 6,211 unvested deferred stock units that vest on August 31, 2020; 48,156 unvested deferred stock units that vest on March 20, 2021; 153,688 shares of restricted stock which vest on August 27, 2021; and 97,150 shares of performance-based restricted stock.
- [F4]Represents common stock indirectly beneficially owned by the reporting person.
- [F5]The reporting person was awarded stock appreciation rights (SARs) which vest as follows: 38,422 on August 27, 2019; 38,422 on August 27, 2020, and 76,844 on August 27, 2021. Each SAR represents the right to receive a payment measured by the increase in the fair market value of one share of common stock from the date of grant of the SAR to the date of exercise of the SAR. Upon exercise, the SARs will be settled in stock.
Documents
Issuer
New York & Company, Inc.
CIK 0001211351
Entity typeother
Related Parties
1- filerCIK 0001238220
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 6:33 PM ET
- Size
- 10.5 KB